Fall's Fantastic Four: Essential Respiratory Vaccines
Live webinar · November 24 · 12:00–1:00 PM ET
Flu, pneumococcal, RSV and COVID-19 vaccines
Developed by Dr. Samir Gupta, Michael Boivin and Dr. Vivien Brown, this dynamic presentation covers four key respiratory immunizations (flu, pneumococcal, RSV and COVID-19) and gives attendees up-to-date information on vaccine effectiveness, including on cardiometabolic outcomes, as well as safety profiles and current national recommendations. Beyond the clinical aspects, we touch on the pressing issues of vaccine hesitancy and fatigue, offering evidence-based approaches to overcome these challenges.
After attending the session, participants will be able to:
Distinguish between RSV, pneumococcal disease, influenza, and COVID-19 in terms of causative agents, transmission, and general epidemiology
Interpret the current national recommendations for each vaccine, including target populations and dosing schedules
Discuss the vaccine effectiveness (including on cardiometabolic outcomes) and safety to allow for a benefit:risk discussion for vaccination
Consider strategies to address vaccine hesitancy in a patient who is a candidate for respiratory vaccines
Discuss a multidisciplinary, collaborative approach to increasing respiratory vaccine uptake
Pharmacist, medical writer and CME planner · RPh, CDE and CBE
Family Physician · MDCM, CCFP, FCFP and MSCP
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program (MOC) of The Royal College of Physicians and Surgeons of Canada and approved by the Canadian Thoracic Society. Live webinar participants may claim a maximum of 1 hour.
This webinar is only for healthcare professionals.
This program was co-developed by the Canadian Thoracic Society and RESPIPLUS, and received funding from Pfizer and Merck. It is planned to achieve scientific integrity, objectivity and balance.